Neurotoxicity of Intrathecally Administered Fentanyl in a Rat Spinal Model

Sayano Fukushima, Tamie Takenami, Saburo Yagishita, Yoshihiro Nara, Sumio Hoka, Hirotsugu Okamoto

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective. Intrathecally administered fentanyl rarely causes drug tolerance or formation of inflammatory masses and might therefore be a suitable treatment option for chronic pain. However, the neurotoxicity of intrathecally administered fentanyl remains to be clarified. We examined the histological changes, neurodysfunction, and side effects of intrathecal fentanyl in rats. Design. The rats received fentanyl at 0.12μL/g body weight (0, 50, 1,000, 2,000, and 5,000μg/mL in saline) via an intrathecal catheter. Seven days after the injection, the spinal cord with both roots were removed for histological examination. The neurological function was evaluated by monitoring walking behavior and latencies to radiant heat. Side effects were also recorded. Results. No histological abnormalities were observed in the spinal cord, anterior and posterior roots, cauda equina nerves, or arachnoid membrane. Formation of white neomembrane was noted around the catheter in some animals, but there was no significant difference in the incidence among the groups. The sensory threshold was significantly higher at 1 and 2 hours after injection in the 50 and 5,000μg/mL groups, respectively. However, there was no significant difference in the sensory threshold among the five groups at 7 days postinjection. All of the rats walked normally within 4 hours even after injection of 5,000μg/mL fentanyl. The incidence of apnea, muscular rigidity, and bradycardia increased significantly at ≥1,000μg/mL dose. Conclusions. The side effects of intrathecally administered fentanyl were concentration-dependent, although no neuronal tissue damage, inflammation, or irreversible neurodysfunction were observed even at 5,000μg/mL.

Original languageEnglish
Pages (from-to)717-725
Number of pages9
JournalPain Medicine
Volume12
Issue number5
DOIs
Publication statusPublished - Jan 1 2011
Externally publishedYes

Fingerprint

Fentanyl
Sensory Thresholds
Injections
Spinal Cord
Catheters
Muscle Rigidity
Drug Tolerance
Arachnoid
Cauda Equina
Incidence
Apnea
Bradycardia
Chronic Pain
Walking
Hot Temperature
Body Weight
Inflammation
Membranes

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Fukushima, S., Takenami, T., Yagishita, S., Nara, Y., Hoka, S., & Okamoto, H. (2011). Neurotoxicity of Intrathecally Administered Fentanyl in a Rat Spinal Model. Pain Medicine, 12(5), 717-725. https://doi.org/10.1111/j.1526-4637.2011.01084.x

Neurotoxicity of Intrathecally Administered Fentanyl in a Rat Spinal Model. / Fukushima, Sayano; Takenami, Tamie; Yagishita, Saburo; Nara, Yoshihiro; Hoka, Sumio; Okamoto, Hirotsugu.

In: Pain Medicine, Vol. 12, No. 5, 01.01.2011, p. 717-725.

Research output: Contribution to journalArticle

Fukushima, S, Takenami, T, Yagishita, S, Nara, Y, Hoka, S & Okamoto, H 2011, 'Neurotoxicity of Intrathecally Administered Fentanyl in a Rat Spinal Model', Pain Medicine, vol. 12, no. 5, pp. 717-725. https://doi.org/10.1111/j.1526-4637.2011.01084.x
Fukushima S, Takenami T, Yagishita S, Nara Y, Hoka S, Okamoto H. Neurotoxicity of Intrathecally Administered Fentanyl in a Rat Spinal Model. Pain Medicine. 2011 Jan 1;12(5):717-725. https://doi.org/10.1111/j.1526-4637.2011.01084.x
Fukushima, Sayano ; Takenami, Tamie ; Yagishita, Saburo ; Nara, Yoshihiro ; Hoka, Sumio ; Okamoto, Hirotsugu. / Neurotoxicity of Intrathecally Administered Fentanyl in a Rat Spinal Model. In: Pain Medicine. 2011 ; Vol. 12, No. 5. pp. 717-725.
@article{53b9f85498ab4cf697382cdf50dad770,
title = "Neurotoxicity of Intrathecally Administered Fentanyl in a Rat Spinal Model",
abstract = "Objective. Intrathecally administered fentanyl rarely causes drug tolerance or formation of inflammatory masses and might therefore be a suitable treatment option for chronic pain. However, the neurotoxicity of intrathecally administered fentanyl remains to be clarified. We examined the histological changes, neurodysfunction, and side effects of intrathecal fentanyl in rats. Design. The rats received fentanyl at 0.12μL/g body weight (0, 50, 1,000, 2,000, and 5,000μg/mL in saline) via an intrathecal catheter. Seven days after the injection, the spinal cord with both roots were removed for histological examination. The neurological function was evaluated by monitoring walking behavior and latencies to radiant heat. Side effects were also recorded. Results. No histological abnormalities were observed in the spinal cord, anterior and posterior roots, cauda equina nerves, or arachnoid membrane. Formation of white neomembrane was noted around the catheter in some animals, but there was no significant difference in the incidence among the groups. The sensory threshold was significantly higher at 1 and 2 hours after injection in the 50 and 5,000μg/mL groups, respectively. However, there was no significant difference in the sensory threshold among the five groups at 7 days postinjection. All of the rats walked normally within 4 hours even after injection of 5,000μg/mL fentanyl. The incidence of apnea, muscular rigidity, and bradycardia increased significantly at ≥1,000μg/mL dose. Conclusions. The side effects of intrathecally administered fentanyl were concentration-dependent, although no neuronal tissue damage, inflammation, or irreversible neurodysfunction were observed even at 5,000μg/mL.",
author = "Sayano Fukushima and Tamie Takenami and Saburo Yagishita and Yoshihiro Nara and Sumio Hoka and Hirotsugu Okamoto",
year = "2011",
month = "1",
day = "1",
doi = "10.1111/j.1526-4637.2011.01084.x",
language = "English",
volume = "12",
pages = "717--725",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Neurotoxicity of Intrathecally Administered Fentanyl in a Rat Spinal Model

AU - Fukushima, Sayano

AU - Takenami, Tamie

AU - Yagishita, Saburo

AU - Nara, Yoshihiro

AU - Hoka, Sumio

AU - Okamoto, Hirotsugu

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Objective. Intrathecally administered fentanyl rarely causes drug tolerance or formation of inflammatory masses and might therefore be a suitable treatment option for chronic pain. However, the neurotoxicity of intrathecally administered fentanyl remains to be clarified. We examined the histological changes, neurodysfunction, and side effects of intrathecal fentanyl in rats. Design. The rats received fentanyl at 0.12μL/g body weight (0, 50, 1,000, 2,000, and 5,000μg/mL in saline) via an intrathecal catheter. Seven days after the injection, the spinal cord with both roots were removed for histological examination. The neurological function was evaluated by monitoring walking behavior and latencies to radiant heat. Side effects were also recorded. Results. No histological abnormalities were observed in the spinal cord, anterior and posterior roots, cauda equina nerves, or arachnoid membrane. Formation of white neomembrane was noted around the catheter in some animals, but there was no significant difference in the incidence among the groups. The sensory threshold was significantly higher at 1 and 2 hours after injection in the 50 and 5,000μg/mL groups, respectively. However, there was no significant difference in the sensory threshold among the five groups at 7 days postinjection. All of the rats walked normally within 4 hours even after injection of 5,000μg/mL fentanyl. The incidence of apnea, muscular rigidity, and bradycardia increased significantly at ≥1,000μg/mL dose. Conclusions. The side effects of intrathecally administered fentanyl were concentration-dependent, although no neuronal tissue damage, inflammation, or irreversible neurodysfunction were observed even at 5,000μg/mL.

AB - Objective. Intrathecally administered fentanyl rarely causes drug tolerance or formation of inflammatory masses and might therefore be a suitable treatment option for chronic pain. However, the neurotoxicity of intrathecally administered fentanyl remains to be clarified. We examined the histological changes, neurodysfunction, and side effects of intrathecal fentanyl in rats. Design. The rats received fentanyl at 0.12μL/g body weight (0, 50, 1,000, 2,000, and 5,000μg/mL in saline) via an intrathecal catheter. Seven days after the injection, the spinal cord with both roots were removed for histological examination. The neurological function was evaluated by monitoring walking behavior and latencies to radiant heat. Side effects were also recorded. Results. No histological abnormalities were observed in the spinal cord, anterior and posterior roots, cauda equina nerves, or arachnoid membrane. Formation of white neomembrane was noted around the catheter in some animals, but there was no significant difference in the incidence among the groups. The sensory threshold was significantly higher at 1 and 2 hours after injection in the 50 and 5,000μg/mL groups, respectively. However, there was no significant difference in the sensory threshold among the five groups at 7 days postinjection. All of the rats walked normally within 4 hours even after injection of 5,000μg/mL fentanyl. The incidence of apnea, muscular rigidity, and bradycardia increased significantly at ≥1,000μg/mL dose. Conclusions. The side effects of intrathecally administered fentanyl were concentration-dependent, although no neuronal tissue damage, inflammation, or irreversible neurodysfunction were observed even at 5,000μg/mL.

UR - http://www.scopus.com/inward/record.url?scp=79955897523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955897523&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4637.2011.01084.x

DO - 10.1111/j.1526-4637.2011.01084.x

M3 - Article

VL - 12

SP - 717

EP - 725

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 5

ER -